Registration Options

Activity Dates: 04/25/2022 - 04/25/2025

AAPP 2022 registration is closed.

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

Orexins (also known as hypocretin) are neuropeptides that acts like neurotransmitters to regulate physiologic functions, including wakefulness, appetite, metabolism, mood, and the reward circuit. The purpose of this session is to outline the quality of evidence to support the use of orexin receptor antagonists and explore what role it may play in the treatment of psychiatric disease states including narcolepsy, addiction, and Alzheimer disease.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Roger Sommi, PharmD, BCPP, FCCP

View biographical information and disclosures

Learning Objectives

  1. Discuss the physiologic function and distribution of excitatory neuropeptides orexin/hypocretin, including a description of the reward circuit. 
  2. Review the evidence and mechanism of currently FDA-approved agents targeting orexin/hypocretin.
  3. Outline current research and possible future targets for these neuropeptides, including narcolepsy, addiction and Alzheimer disease.

Continuing Education Credit and Disclosures

Activity Dates: 04/25/2022 - 04/25/2025
ACPE Contact Hours: 1
ACPE Number: 0284-0000-22-037-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.